Companies / Anacor Pharmaceuticals, Inc.
Anacor Pharmaceuticals, Inc.
ANACCIK 1411158
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 19, 2015 | Berns Paul L CEO | Sell Open-market sale | Common Stock | $2.10M | -38K -10.83% | 308,760 | medium |
| Mar 16, 2015 | Plattner Jacob j Executive | Sell Open-market sale | Common Stock | $496.0K | -9K -20.00% | 35,680 | medium |
| Mar 16, 2015 | Zane Lee Executive | Sell Open-market sale | Common Stock | $444.5K | -8K -19.67% | 32,256 | medium |
| Mar 3, 2015 | Ippolito Vincent P Executive | Sell Open-market sale | Common Stock | $343.8K | -8K -9.86% | 71,757 | medium |
| Mar 2, 2015 | Plattner Jacob j Executive | Sell Open-market sale | Common Stock | $284.8K | -6K -12.58% | 45,000 | medium |
| Feb 2, 2015 | Plattner Jacob j Executive | Sell Open-market sale | Common Stock | $256.8K | -7K -11.78% | 51,475 | medium |
| Mar 16, 2015 | Zane Lee Executive | Sell Open-market sale | Common Stock | $232.7K | -4K -12.71% | 28,156 | medium |
| Mar 4, 2015 | Chanda Sanjay Executive | Sell Open-market sale | Common Stock | $222.8K | -5K -14.55% | 29,087 | medium |